Literature DB >> 11473864

The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C.

S H Do1, G L Kamatchi, M E Durieux.   

Abstract

UNLABELLED: By using two electrode voltage clamps, we investigated the effects of isoflurane on m3 and chimeric m1/m3 muscarinic receptors and the role of protein kinase C (PKC) in the effects. Muscarinic receptors were expressed by injection of mRNA into Xenopus oocytes, and Ca(2+)-activated Cl(-) currents were measured after the application of acetyl-beta-methylcholine. We constructed chimeric m1/m3 receptor DNA encoding the third intracellular loop of m1 and the remainder from the m3 receptor. Chimeric and m3 receptors were inhibited by isoflurane, but the m1 receptor was not. PKC activation with phorbol-12-myrisate-13-acetate (50 nM) decreased signaling of both chimeric and m3 receptors significantly. Chelerythrine (20 microM, PKC inhibitor) abolished the effect of isoflurane on chimeric and m3 signaling. Whereas isoflurane inhibition of chimeric and m3 receptors was completely reversible after washout with Tyrode's solution for 3 min, treatment with okadaic acid (500 nM, protein phosphatase inhibitor) rendered the inhibition irreversible. Taken together, our results suggest that isoflurane inhibits m3 and chimeric m1/m3 muscarinic signaling by enhancing PKC activity and that the site of action is located outside of the third intracellular loop. IMPLICATIONS: By use of the Xenopus oocyte expression system, we investigated the effects of isoflurane on muscarinic signaling and the role of protein kinase C in these effects. Our findings suggest that isoflurane inhibits muscarinic receptors through activation of protein kinase C and that the relevant phosphorylation sites are located outside the third intracellular loop.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473864     DOI: 10.1097/00000539-200108000-00028

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  Mechanism of action of volatile anesthetics: role of protein kinase C.

Authors:  Renato Santiago Gomez; Cristina Guatimosim; Marcus Vinicius Gomez
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

Review 2.  Neurochemical modulators of sleep and anesthetic states.

Authors:  Christa J Van Dort; Helen A Baghdoyan; Ralph Lydic
Journal:  Int Anesthesiol Clin       Date:  2008

3.  The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors.

Authors:  Takafumi Horishita; Kouichiro Minami; Yasuhito Uezono; Munehiro Shiraishi; Junichi Ogata; Takashi Okamoto; Tadanori Terada; Takeyoshi Sata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-03-19       Impact factor: 3.000

Review 4.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

Review 5.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

6.  Inhalation anaesthetic isoflurane inhibits the muscarinic cation current and carbachol-induced gastrointestinal smooth muscle contractions.

Authors:  Dariia Dryn; Jialie Luo; Mariia Melnyk; Alexander Zholos; Hongzhen Hu
Journal:  Eur J Pharmacol       Date:  2017-12-02       Impact factor: 4.432

7.  Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells.

Authors:  Atsushi Takizuka; Kouichiro Minami; Yasuhito Uezono; Takafumi Horishita; Toru Yokoyama; Munehiro Shiraishi; Takeshi Sakurai; Akio Shigematsu; Yoichi Ueta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-12       Impact factor: 3.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.